These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18506754)

  • 1. Severe chronic refractory immune thrombocytopenic purpura during childhood: a survey of physician management.
    Neunert CE; Bright BC; Buchanan GR
    Pediatr Blood Cancer; 2008 Oct; 51(4):513-6. PubMed ID: 18506754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The response to treatment in chronic idiopathic thrombocytopenic purpura (ITP).
    Eldor A; Gillis S; Ben-Yehuda D
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():69-70. PubMed ID: 7886611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
    Cooper N; Evangelista ML; Amadori S; Stasi R
    Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of children with idiopathic thrombocytopenic purpura, based on original material.
    Zawitkowska-Klaczyńska J; Nurzyńska-Flak J; Kattski K; Kowalczyk JR
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):194-7. PubMed ID: 16146076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
    Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR;
    Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
    Aggarwal A; Catlett JP
    South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic immune thrombocytopenic purpura in children: a survey of the canadian experience.
    Belletrutti M; Ali K; Barnard D; Blanchette V; Chan A; David M; Luke B; Price V; Ritchie B; Wu J; ;
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):95-100. PubMed ID: 17279005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin.
    Hemmila MR; Foley DS; Castle VP; Hirschl RB
    J Pediatr Surg; 2000 Jun; 35(6):967-71; discussion 971-2. PubMed ID: 10873046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe chronic idiopathic thrombocytopenic purpura during childhood: definition, management, and prognosis.
    Buchanan GR; Journeycake JM; Adix L
    Semin Thromb Hemost; 2003 Dec; 29(6):595-603. PubMed ID: 14719176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of childhood idiopathic thrombocytopenic purpura: a survey of members of the French Society of Pediatric Hematology and Immunology (SHIP)].
    Lutz P; Villega F; Ducassou S; Entz-Werle N; Michel G;
    Arch Pediatr; 2007 May; 14(5):444-9. PubMed ID: 17229559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group.
    Kühne T; Blanchette V; Buchanan GR; Ramenghi U; Donato H; Tamminga RY; Rischewski J; Berchtold W; Imbach P;
    Pediatr Blood Cancer; 2007 Nov; 49(6):829-34. PubMed ID: 17171689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic refractory ITP in children: beyond splenectomy.
    Sevier N; Houston M
    J Pediatr Oncol Nurs; 2005; 22(3):145-51. PubMed ID: 15855475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura.
    Holt D; Brown J; Terrill K; Goldsby R; Meyers RL; Heximer J; Nordfors B; Slayton WB
    Pediatrics; 2003 Jan; 111(1):87-90. PubMed ID: 12509559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.